DRUG MAFFIA

Pfizer Violated Own Rules to Hide Depression Drug Studies

Pfizer is accused of “deception through concealment” and “cheating” in failing to disclose nine of 16 trials of an antidepressant, Edronax (reboxetine), in Germany. The German Institute for Quality and Efficiency in Health Care slammed Pfizer in a press release titled: Pfizer conceals study data; Drug manufacturer hinders the best possible treatment of patients with depression Essex Pharma was also noted for not being completely upfront about its antidepressant, mirtazapine, and the Institute praised GlaxoSmithKline in the same set of statements for providing a full database of studies for bupropion XL. Pfizer’s refusal to disclose its studies violates its own published policy about studies. That policy states: In all cases, study results are reported by Pfizer in an objective, accurate, balanced, and complete manner and are reported regardless of the outcome of the study or the country in which the study was conducted.